Newswise COVID Experts

Filters close
Released: 4-Oct-2023 10:05 AM EDT
MSU expert: What to know about flu, RSV, new COVID-19 variant and new vaccine
Michigan State University

The new COVID-19 EG.5 variant is responsible for around 22% of current cases. The World Health Organization has classified it as a “variant of interest,” meaning countries should monitor it more closely than other strains — and cases have only increased in the past few weeks. Peter Gulick is an expert on infectious diseases, and he provides insight on what this new variant could mean and what you should know.

Newswise: The Medical Minute: Uptick in COVID cases, new vaccine available
Released: 4-Oct-2023 8:05 AM EDT
The Medical Minute: Uptick in COVID cases, new vaccine available
Penn State Health

Cases of COVID-19 are up since this summer, and a new vaccine is available. A Penn State Health infectious disease expert offers the latest on the pandemic.

Newswise: New Nobel Prize in Medicine winner Katalin Karikó, launched career at USU
Released: 3-Oct-2023 11:05 AM EDT
New Nobel Prize in Medicine winner Katalin Karikó, launched career at USU
Uniformed Services University of the Health Sciences (USU)

A biochemist who got her start at the Uniformed Services University (USU), Dr. Katalin Karikó, was awarded the Nobel Prize in Medicine on Oct. 2 for her key discoveries that led to the development of the mRNA vaccines against COVID-19.

Newswise: image.png
Released: 3-Oct-2023 10:05 AM EDT
Not all viruses are harmful
Virginia Tech

During the COVID-19 pandemic, people became well aware that viruses can be extremely harmful. But can viruses also be helpful? Bryan Hsu aims to find out by studying viruses that infect bacteria in the bellies of mammals. 

Released: 3-Oct-2023 6:05 AM EDT
Pharmacists can improve access to life-saving vaccines
University of Waterloo

HPV, or human papillomavirus, is the most common sexually transmitted infection. It is also the leading cause of cervical cancer. Over 1,400 Canadian women are affected yearly, with almost 400 deaths, according to the Canadian Cancer Society.

Newswise: Immunologist Awarded 2023 Nobel Prize in Medicine for mRNA Vaccine Research
Released: 2-Oct-2023 4:45 PM EDT
Immunologist Awarded 2023 Nobel Prize in Medicine for mRNA Vaccine Research
American Association of Immunologists (AAI)

No fewer than 28 immunologists have received the Nobel Prize since 1901, highlighting the importance of immunology to health

Released: 2-Oct-2023 4:05 PM EDT
Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2
Ohio State University

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Newswise: Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
Released: 2-Oct-2023 12:05 PM EDT
Initiative to Strengthen Response to Infectious Disease Outbreaks in the Mountain West
University of Utah Health

The COVID-19 pandemic spotlighted how a rapid and effective response to infectious disease outbreaks is critical for saving lives and protecting communities. With a $17.5 million, five-year grant from the U.S. Centers for Disease Control and Prevention (CDC), University of Utah researchers, in collaboration with Washington State University, are leading efforts to provide data and tools that guide decisions to improve responses to emerging public health threats in the Mountain West.



close
2.2739